Greenwich Lifesciences Inc (GLSI) Live Share Price, Invest From India

Greenwich Lifesciences Inc Stock Performance

as on October 25, 2025 at 1:29 am IST

Day's Low
Day's High
$9.29
Day's Price Range
$10
$9.95
6.63%
Downside
0.50%
Upside
52 Week's Low
52 Week's High
$8.06
52-Week Price Range
$15.47
$9.95
18.99%
Downside
55.48%
Upside

Greenwich Lifesciences Inc share price movements today

Previous Close: $9.19
Open: $9.34
Volume: 410.1K
Day's Low - High: $9.29 - $10
52 Week Low - High: $8.06 - $15.47

Greenwich Lifesciences Inc Historical Returns

1 Month Return: -4.13 %
3 Month Return: -13.66 %
1 Year Return: -26 %
3 Year Return: -0.79 %
5 Year Return: + 138.14 %

Greenwich Lifesciences Inc Stock Fundamentals & Key Indicators

Check Greenwich Lifesciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$125.3M

EPS (TTM)

-1.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-18.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-491.94%

Greenwich Lifesciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Greenwich Lifesciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Greenwich Lifesciences Inc	BUY	$125.3M	138.14%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.9B	251.51%	-505.15	-12.96%
Beone Medicines Ltd	NA	$35.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$109.3B	99.16%	30.04	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$62.0B	-0.32%	14.51	31.37%

Stock Returns calculator for Greenwich Lifesciences Inc Stock including INR - Dollar returns

The Greenwich Lifesciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Greenwich Lifesciences Inc investment value today

Current value as on today

₹78,310

Returns

₹21,690

(-21.69%)

Returns from Greenwich Lifesciences Inc Stock

₹26,296 (-26.3%)

Dollar Returns*

₹4,606 (+4.61%)

Analyst Recommendation on Greenwich Lifesciences Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Greenwich Lifesciences Inc. Average target price of $45

Greenwich Lifesciences Inc Share Price Target

Get share price movements and forecasts by analysts on Greenwich Lifesciences Inc.

What analysts predicted

77.89%UPSIDE

Target Price

$45

Current Price

$9.95

Analyzed by

7 Analysts

Target

$45.00

Greenwich Lifesciences Inc target price $45, a slight upside of 77.89% compared to current price of $9.95. According to 7 analysts rating.

Greenwich Lifesciences Inc Stock’s Investor Sentiment and Interest

Search interest for Greenwich Lifesciences Inc Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 27, 2025 to October 27, 2025

Change:-50% versus previous 30 day period

Greenwich Lifesciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	0	-	-	-	0	-
Gross Profit	0	0	0	-	0	0	0	-	0	0
Operating Income	-2	-1	-2	-2	-2	-2	-2	-8	-3	-4
EBITDA	-2	-1	-2	-	-2	-2	-2	-	-3	-4
Interest Expense	0	-	-	-	0	-	-	-	0	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-1	-2	-2	-2	-2	-2	-8	-3	-4
Income Tax Expense	0	0	0	-	0	0	-	-	2	-
Net Income	-2	-1	-2	-2	-2	-2	-2	-8	-3	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-45647.75%	0.00%	0.00%	0.00%	-90209.36%	0.00%

Greenwich Lifesciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-1	-3	-1	-4	-8	-9	-16
EBITDA	-1	-3	-1	-4	-8	-9	-15
Interest Expense	-	-	-	0	0	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-1	-3	-1	-4	-7	-8	-15
Income Tax Expense	0	0	0	0	0	0	-
Net Income	-1	-3	-1	-4	-7	-8	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Greenwich Lifesciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-1	-2	-2	-2	-2	-2	-8	-3	-4
Operating Cash Flow	0	-1	-2	-1	-1	-2	-1	-1	-2
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	-	-	-	0	2	1	0	0	2
Change in Cash	0	-1	-2	-1	1	-1	-1	-1	0

Greenwich Lifesciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-1	-3	-1	-4	-7	-8	-15
Operating Cash Flow	0	0	-1	-4	-6	-6	-7
Investing Cash Flow	-	-	-	-	-	-	-
Financing Cash Flow	0	0	29	2	-7	-	4
Change in Cash	0	0	28	-1	-13	-6	-2

Global Institutional Holdings in Greenwich Lifesciences Inc

Funds	Holdings
BlackRock Inc	2.69%
Vanguard Group Inc	1.97%
Geode Capital Management, LLC	1.02%
Crédit Agricole S.A.	0.64%
Northern Trust Corp	0.61%

See all

Greenwich Lifesciences Inc News & Key Events

Insights on Greenwich Lifesciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, GLSI stock has moved up by 5.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 130.5% return, outperforming this stock by 129.4%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.7% return, outperforming this stock by 88.7%

About Greenwich Lifesciences Inc

Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9-amino acid transmembrane peptide of the human epidermal growth factor receptor 2 (HER2) /neu protein, a cell surface receptor protein that is expressed in a variety of common cancers. It has commenced a Phase III clinical trial, Flamingo-01, an immunotherapy to prevent breast cancer recurrences. GP2 is delivered in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce GP2 peptide-specific immunity. GP2 treatment is administered via an intradermal injection by mixing GP2 peptide and GM-CSF at the time of administration. Its cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells while not affecting normal cells or to deliver immune system components to inhibit the spread of cancer.

Organisation	Greenwich Lifesciences Inc
Headquarters	Building 14, Stafford, TX, United States, 77477
Industry	Health Technology
CEO	Mr. Snehal S. Patel
E-voting on shares	Click here to vote

Key Management of Greenwich Lifesciences Inc

Name	Title
Mr. Snehal S. Patel	CEO, CFO & Director
Mr. Eric Rothe	Founder & Independent Director
Dr. Frank Joseph Daugherty M.D.	Chief Medical Officer & Director
Dr. Jaye L. Thompson Ph.D.	Vice President Clinical & Regulatory Affairs
Dr. Christine T. Fischette Ph.D.	VP of Business Development

FAQs

What is Greenwich Lifesciences Inc share price today?

Greenwich Lifesciences Inc share price today is $9.95 as on October 25, 2025 at 1:29 am IST at the close of the market. Greenwich Lifesciences Inc share today touched a day high of $10 and a low of $9.29.

What is the 52 week high and 52 week low for Greenwich Lifesciences Inc share?

Greenwich Lifesciences Inc share touched a 52 week high of $15.47 on December 2, 2024 and a 52 week low of $8.06 on April 7, 2025. Greenwich Lifesciences Inc stock price today i.e. October 25, 2025 at 1:29 am IST is closed at $9.95,which is 35.68% down from its 52 week high and 23.45% up from its 52 week low.

What is Greenwich Lifesciences Inc's market capitalisation today?

Greenwich Lifesciences Inc market capitalisation is $0.00T as on October 25, 2025 at 1:29 am IST.

How to invest in Greenwich Lifesciences Inc Stock (GLSI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Greenwich Lifesciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Greenwich Lifesciences Inc Shares that will get you 0.1508 shares as per Greenwich Lifesciences Inc share price of $9.95 per share as on October 25, 2025 at 1:29 am IST.

What is the minimum amount required to buy Greenwich Lifesciences Inc Stock (GLSI) from India?

Indian investors can start investing in Greenwich Lifesciences Inc (GLSI) shares with as little as ₹87.796 or $1 (as of October 27, 2025 at 12:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹877.96 in Greenwich Lifesciences Inc stock (as per the Rupee-Dollar exchange rate as on October 27, 2025 at 12:37 am IST). Based on Greenwich Lifesciences Inc share’s latest price of $9.95 as on October 25, 2025 at 1:29 am IST, you will get 1.0050 shares of Greenwich Lifesciences Inc. Learn more about fractional shares .

What are the returns that Greenwich Lifesciences Inc has given to Indian investors in the last 5 years?

Greenwich Lifesciences Inc stock has given 138.14% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?